NAPROXEN
- Product NDC
- 70934-455
- 11-digit product format
- 709340455
- Labeler code
- 70934
- Product ID
- 70934-455_b7ae9583-b5b4-97e3-e053-2a95a90a701d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NAPROXEN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA091416
- Marketing category
- ANDA
- Marketing start
- 2019-10-22
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN
- Active strength
- 375 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-455-30 | 70934045530 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-455-30) | 30 tablet | 2019-10-22 | 0000-00-00 | No | No | Current |